RMD
Resmed CDI
Healthcare Equipment and Supplies
·
Healthcare
71
comments
29
fund managers
past 90 days
About Resmed CDI
ResMed, Inc. is a digital health company specializing in cloud-connected medical devices for sleep apnea, COPD, and other chronic diseases. Founded in 1989 and headquartered in San Diego, CA, ResMed operates through two primary segments: Sleep and Respiratory Care and Software as a Service (SaaS). The Sleep and Respiratory Care segment focuses on medical devices for sleep and respiratory disorders. The SaaS segment provides business management software for out-of-hospital healthcare providers. ResMed’s technologies aim to improve patient outcomes through integrated digital health solutions.
Commentary Volume
71
Comments
29
Fund managers
0
Past 90 days
SOURCE
ACTION
COMMENT PREVIEW
FUND MANAGER
DATE
Loading...
.
Loading...
Loading...
Loading...
Loading...
Source: Ipsum Capital Q4 Quarterly Letter · Published 14 March 2025
Report a problem
Loading...
.
Loading...
Loading...
Loading...
Loading...
§ Important Notice
The entries below are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Commentary
Sector
Healthcare
Market cap
$3B
Fund managers
29 managers
First covered
30 Sept 2023
Last updated
8 May 2026
Company Details
Related Themes
ic
Ipsum Capital
6 comments
ic
Amet Funds
4 comments
ic
Dolor
3 comments
Top Investors Covering MIN
§ Reminder
The entries above are records originating from third-party statements. Thesis Tracker does not rank, recommend or endorse any fund manager, fund or security. Investment decisions should be made on the basis of the relevant Product Disclosure Statement and, where appropriate, advice from a licensed adviser.
Frequently asked questions about Resmed CDI (ASX:RMD)
Frequently asked questions
Who is investing in Resmed CDI (ASX:RMD)?
Fund managers including L1 Capital, Endeavor Asset Management, Blackwattle Investment Partners, Oracle Advisory Group, Equity Trustees Asset Management, Cordis Asset Management, Pengana Capital Group, Totus Capital, Swell Asset Management, Airlie Funds Management, ELM Responsible Investments, ECP Asset Management, Selector Funds Management, Clime Investment Management, Sterling Managed Investments, Alliance Bernstein, SG Hiscock & Company, Alphinity Investment Management, Yarra Capital Management, Pendal Group, Auscap Asset Management, Infinity Asset Management, NAOS Asset Management, Paradice Investment Management, Wilson Asset Management, TMS Capital, Flagship Investments, Perennial Partners and Katana Asset Management have invested in Resmed CDI (ASX:RMD).
What is the short interest in Resmed CDI (ASX:RMD)?
The short interest in Resmed CDI (ASX:RMD) is 0.17% which makes it the 365th most shorted stock on the ASX. Of the 579.4M shares that Resmed CDI has on issue, 1.0M have been sold short.
What does Resmed CDI (ASX:RMD) do?
ResMed, Inc. is a digital health company specializing in cloud-connected medical devices for sleep apnea, COPD, and other chronic diseases. Founded in 1989 and headquartered in San Diego, CA, ResMed operates through two primary segments: Sleep and Respiratory Care and Software as a Service (SaaS). The Sleep and Respiratory Care segment focuses on medical devices for sleep and respiratory disorders. The SaaS segment provides business management software for out-of-hospital healthcare providers. ResMed’s technologies aim to improve patient outcomes through integrated digital health solutions.
Loading...